This article discusses the production process of the major influenza antigen, hemagglutinin (HA), by rDNA methods in E. coli.
Alan Shaw, PhD
Advertisement
President and CEO of VaxInnate
Articles by Alan Shaw, PhD
Advertisement
Latest Updated Articles
Vaccines Incorporating Toll-Like Receptor LigandsPublished: October 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
